STOCK TITAN

Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Applied DNA Sciences, Inc. (NASDAQ: APDN) will announce its fiscal 2021 first quarter financial results on February 11, 2021, after the market closes. A conference call and webcast led by CEO Dr. James A. Hayward, CFO Beth Jantzen, and COO Judith Murrah will follow at 4:30 p.m. ET. The webcast and PowerPoint presentation will be accessible on the company’s website and archived for future viewing. The company specializes in molecular technologies for supply chain security, anti-counterfeiting, and product genotyping.

Positive
  • Upcoming financial results announcement may provide insights into growth.
  • Conference call scheduled to discuss results, enhancing investor transparency.
Negative
  • None.

Applied DNA Sciences, Inc. (NASDAQ: APDN) announced today that it will report fiscal 2021 first quarter financial results after market close on Thursday, February 11, 2021. The Company’s management will discuss the results during a conference call and simultaneous webcast at 4:30 p.m. ET that same day. Presentation slides will also be posted to the ‘IR Calendar’ section of the Company’s corporate website and embedded into the live webcast.

Conference Call and Webcast Information - Live

Date:

Thursday, February 11, 2021, at 4:30 p.m. Eastern Daylight Time

Dial in:

844-887-9402

412-317-6798 (international)

Conference ID: 10151013

Hosts:

Dr. James A. Hayward, chairman, president, and CEO

Beth Jantzen, chief financial officer

Judith Murrah, chief operating officer

Webcast:

https://services.choruscall.com/links/apdn210211.html

Conference Call and Webcast Information - Replay

A telephonic replay of the conference call will be available for one week beginning one hour after the end of the live conference call.

Dial in:

877-344-7529

412-317-0088 (international)

Conference ID: 10151013

Webcast:

https://services.choruscall.com/links/apdn210211.html

Availability:

Telephonic replay: until Thursday, February 18, 2021; webcast replay: 1 year

The webcast and accompanying PowerPoint presentation will also be archived on the ‘IR Calendar’ page listed under the Investor Relations drop-down menu on the Company’s website.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, and pre-clinical nucleic acid-based therapeutic drug candidates.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under ticker symbol ‘APDN’, and its publicly traded warrants are listed on OTC under ticker symbol ‘APPDW’.

Applied DNA is a member of the Russell Microcap® Index.

Forward-Looking Statements

The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to, its history of net losses, limited financial resources, limited market acceptance, the uncertainties inherent in research and development, our ability to successfully enter into commercial contracts for the implementation of our CertainT® platform, disruptions in the supply of raw materials and supplies, and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 17, 2020, and other reports we file with the SEC, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law.

FAQ

When will Applied DNA Sciences (APDN) report its Q1 2021 financial results?

Applied DNA Sciences will report its Q1 2021 financial results on February 11, 2021, after market close.

What time is the conference call for Applied DNA Sciences (APDN) Q1 2021 results?

The conference call for Applied DNA Sciences' Q1 2021 results is scheduled for 4:30 p.m. ET on February 11, 2021.

Who will host the Applied DNA Sciences (APDN) conference call?

The conference call will be hosted by Dr. James A. Hayward, CEO, along with CFO Beth Jantzen and COO Judith Murrah.

How can I access the Applied DNA Sciences (APDN) conference call webcast?

You can access the Applied DNA conference call webcast at https://services.choruscall.com/links/apdn210211.html.

What is the significance of the upcoming financial results for Applied DNA Sciences (APDN)?

The upcoming financial results may provide insights into the company’s growth and performance, important for investors.

Applied DNA Sciences, Inc.

NASDAQ:APDN

APDN Rankings

APDN Latest News

APDN Stock Data

9.37M
41.55M
0.62%
0.5%
0.94%
Diagnostics & Research
Services-testing Laboratories
Link
United States of America
STONY BROOK